The Effects of Endotoxin–Contaminated Dialysate and Polysulfone or Cellulosic Membranes on the Release of TNFα during Simulated Dialysis

Artificial Organs

Volumn 19, Issue 9, 1995, Pages 880-886

  Arduino, Matthew J ^a   Bland, Lee A ^a   McAllister, Sigrid K ^a   Favero, Martin S ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Biocompatibility; Endotoxin; Hemodialysis; Tumor necrosis factor

Indexed keywords

BIOCOMPATIBILITY; BLOOD; GLYCOPROTEINS; HEMODIALYZERS; MACROPHAGES; TUMORS;

BLOOD SAMPLES; DIALYSATES; ENDOTOXIN; HAEMODIALYSIS; LIMULUS AMEBOCYTE LYSATE; POLYSULPHONE; REGENERATED CELLULOSE; TRANSMEMBRANES; TUMOR NECROSIS FACTORS; WHOLE BLOOD;

DIALYSIS;

CELLULOSE; ENDOTOXIN; POLYSULFONE; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BIOCOMPATIBILITY; HEMODIALYSIS; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

LIMULUS;

EID: 0028874521     PISSN: 0160564X     EISSN: 15251594     Source Type: Journal    
DOI: 10.1111/j.1525-1594.1995.tb02446.x     Document Type: Article

References (28)

1. National surveillance of hemodialysis associated diseases in the United States
2. Microbial contamination of renal disease systems and associated health risks
3. Microbiologic guidelines for hemodialysis systems
4. Bacteriological and clinical evaluation of different dialysate delivery systems
5. Absence of bacteremia and endotox–emia despite contaminated dialysate
6. Lack of plasma interleukin–10 or tumor necrosis factor–α elevation during unfavorable hemodialysis conditions
7. Bacterial and endotoxin permeability of hemodialysis membranes
8. No evidence of endotoxin transfer across high flux polysulfone membranes
9. Induction of IL–1 during hemodialysis: transmembrane passage of intact endotoxin (LPS)
10. Detection of endotoxin–like interleukin–1–inducing activity during in vitro dialysis
11. Dialysate contamination and back filtration may limit the use of high–flux dialysis membranes
12. Sterile versus non–sterile dialysis fluid in chronic hemodialysis treatment
13. The role of dialysate in the stimulation of interleukin–1 production during clinical hemodialysis
14. Interleukin–1β in human plasma: optimization of blood collection, plasma extraction, and radioimmunoassay methods
15. Association for the Advancement of Medical Instrumentation
16. A sensitive chro–mogenic Limulus amoebocyte lysate micro–assay for detection of endotoxin in human plasma and in water
17. Optimization of detection of bacterial endotoxin in plasma with the Limulus test
18. Principles of a quantitative assay for bacterial endotoxins in blood that uses the Limulus lysate and a chro–mogenic substance
19. Hemodialysis Does the membrane matter
20. Transcription, not synthesis, of interleukin–1 and tumor necrosis factor by complement
21. Comparison of chemical analyses of hollow–fiber dialyzer extracts
22. Macrophage stimulation by bacterial lipopolysaccharides II. Evidence for differential signals delivered by lipid A and by a protein rich fraction of lipopoly saccharides
23. Human interleukin–1 production during hemodialysis
24. Ultrafiltration to reject human interleukin–1–inducing substances derived from bacterial cultures
25. Potency of endotoxin from bicarbonate dialysate compared to endotoxins from Escherichia coli and Shigella flexneri
26. Cytokine kinetics in an in vitro whole blood model following an endotoxin challenge
27. Comparative pyrogenicity of rabbit and man to bacterial endotoxin
28. Lack of plasma interleukin–1β or tumor necrosis factor–α elevation during unfavorable hemodialysis conditions